ORGANOCLICK AB (PUBL) PUBLISH INTERIM REPORT FOR Q3 2024

"During the third quarter, the trend of good growth continued for our consumer brands, while our industrial products continued to face a challenging market situation. Despite a sales decrease of -14 (50) percent to MSEK 28.9 (33.4) during the quarter, our operating profit/loss was in line with the third quarter of 2023 at MSEK -3.0 (-2.8), thanks to the changed product mix and sound cost control. For the first nine months of the year (Jan–Sept), the operating profit/loss was also in line with the previous year at MSEK -3.0 (-3.1), while cash flow from operating activities was significantly improved to MSEK -1.1 (-6.1)."

Translation from CEO Mårten Hellbergs comments to the Interim Report.

Q3, 1 July – 30 September 2024

The Group compared with 2023

» Net revenue amounted to SEK 28.88 (33.45)million

» The gross margin amounted to 23.0 (23.8)%

» EBIT amounted to SEK -3.01 (-2.81)million

» Cash-flow from operating activities amounted to SEK -1.66 (1.05)million

1 January – 30 September 2024

The Group compared with2023

» Net revenue amounted to SEK 105.80 (117.96)million

» The gross margin amounted to 27.5 (25.6)%

» EBIT amounted to SEK -2.99 (-3.10)million

» Cash-flow from operating activities amounted to SEK -1.10 (-6.13)million

The complete version of the Interim Report is attached in this press release and is available on the companys´homepage. The informationen in this Interim Report is according to the rulesof Nasdaq First North Growth Market.

This disclosure contains information that OrganoClick AB is obliged to make public pursuant to the EU Market Abuse Regulation (EU nr 596/2014). The information was submitted for publication, through the agency of the contact person, on 06-11-2024 08:30 CET.